A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors

NCT02210663 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie